SLE (Systemic Lupus)

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain

Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)

A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus

Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity

Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients

Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia

Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA